Batavia Biosciences
Business Services · Netherlands · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Zernikedreef 16, Leiden, South Holland, ...Phone Number
+31 889950600Website
www.bataviabiosciences.comRevenue
$21.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
2
1
1
About Batavia Biosciences
Founded in 2010, Batavia Biosciences is a biopharmaceutical contract development and manufacturing organization specializing in vaccine's, monoclonal antibody, and recombinant protein development. Batavia Biosciences is located in the NetherlandsExplore more
Batavia Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Batavia Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Batavia Biosciences launches new products
Click to see if Batavia Biosciences had a recent Job posting/layoffs
Check out if Batavia Biosciences is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check if Batavia Biosciences has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Batavia Biosciences recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Batavia Biosciences
Batavia Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Batavia Biosciences has new funding data
Recommended Actions
Reach out to Masked Content who joined Batavia Biosciences as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Batavia Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Batavia Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Batavia Biosciences.
Batavia Biosciences financials insights
Gather financial insights about Batavia Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Grant
$8M
Batavia Biosciences Tech Stack
A closer look at the technologies used by Batavia Biosciences
See more technologies
Most Recent Scoops
Event
Events
Open Position
Open Position
Open Position
Open Position
Batavia Biosciences News & Media
ChromaTan and Batavia Receive NIIMBL Grant to Integrate Column-Free Steady-State Continuous Elution Chromatography Into HIP-Vax® Manufacturing Platform for AAV
LOWER GWYNEDD, Pa.--(BUSINESS WIRE)--ChromaTan, a bioprocessing and biotools advanced biomanufacturing technology platform development company, is excited to announce an alliance with Batavia Biosciences, a leading contract development and manufacturing organization, for the development and integration of ChromaTan’s BioRMBTM continuous counter-current elution technology into Batavia’s AAV HIP-Vax® manufacturing platform. This project further highlights ChromaTan’s and Batavia’s commitment to iBatavia Biosciences Optimizes Global Quality Assurance with Veeva Vault Quality Suite
Global CDMO boosts GxP compliance and inspection readiness with Veeva quality applications PLEASANTON, Calif., Sept. 15, 2022 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Batavia Biosciences selected Veeva Vault Quality Suite to optimize its global quality assurance (QA),...Batavia Biosciences and Valneva Collaborate to Accelerate Development of Low-cost Inactivated Polio Vaccine
Leiden, Netherlands and Saint-Herblain, France, June 15, 2020 – Batavia Biosciences (“Batavia”) and Valneva Sweden AB, the Swedish subsidiary of Valneva SE (“Valneva”), today announced that they have entered into a collaboration agreement to accelerate market-access of a low-cost inactivated polio vaccine (IPV). This work is supported under GPEI.1Batavia Biosciences receives $6.5M grant to take next step towards polio-free world
Leiden, the Netherlands, Sep 16, 2019 – Today, Batavia Biosciences announces it received a grant of $6.5 million from the Bill & Melinda Gates Foundation to develop a manufacturing process for a novel oral vaccine against polio virus type 2 strain (nOPV2) to help protect children worldwide from future polio outbreaks.
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Batavia Biosciences
Sign Up For FreeTo access detailed company insights
Founded in 2010, Batavia Biosciences is a biopharmaceutical contract development and manufacturing organization specializing in vaccine's, monoclonal antibody, and recombinant protein development. Batavia Biosciences is located in the Netherlands... Read More
